If You Invested $1000 in Veeva Systems a Decade Ago, This is How Much It'd Be Worth Now

How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across sectors and industries as well.Another factor that can influence investors is FOMO, or the fear of missing out, especially with tech giants and popular consumer-facing stocks.What if you'd invested in Veeva Systems (VEEV) ten years ago? It may not have been easy to hold on to VEEV for all that time, but if you did, how much would your investment be worth today?Veeva Systems' Business In-DepthWith that in mind, let's take a look at Veeva Systems' main business drivers.Veeva Systems Inc. is headquartered in Pleasanton, CA and provides industry cloud solutions for the global life sciences market. Its offerings span cloud software, data, artificial intelligence capabilities and business consulting, supporting customers from research and development through commercialization. Veeva operates as a single reportable segment and groups revenues into Commercial Solutions and R&D and Quality Solutions. Commercial Solutions include Veeva Commercial Cloud applications and Veeva Data Cloud. Key products include Veeva CRM, Vault CRM, Veeva Network and data offerings such as OpenData and Compass, along with Crossix for digital measurement. Veeva Systems has also released its advanced Veeva Commercial Cloud offering, Veeva CRM Engage Webinar, at the Veeva Commercial Summit Europe. Veeva Systems also released Veeva Vault PromoMats Brand Portal — a new digital asset management capability that helps brand managers create portals, organize and showcase content within Veeva Vault PromoMats. Veeva Systems has also announced the availability of the whole suite of commercial data products from Veeva Compass Suite for a more comprehensive understanding of patient groups and HCP-level information.Veeva CRM is delivered on the Salesforce platform, while Vault CRM is built on the Veeva Vault platform and is the company’s migration path for existing CRM customers. R&D and Quality Solutions include Veeva Development Cloud and Veeva Quality Cloud products, which are utilized in clinical, regulatory, safety, quality and manufacturing workflows, featuring modules such as eCOA, RTSM, EDC, Safety and LIMS.FY26 at a GlanceFor fiscal 2026, VEEV registered total sales of $3.19 billion, up 16% year over year. VEEV reported adjusted earnings per share of $8.10 for fiscal 2026, up 22.7% compared with fiscal 2025.Subscription Service revenues were $2.68 billion (84% of net sales, up 17.5% from fiscal 2025), while Professional services and other revenues grossed $511.1 million (16%, up 10%). Bottom LineAnyone can invest, but building a successful investment portfolio requires research, patience, and a little bit of risk. So, if you had invested in Veeva Systems, ten years ago, you're likely feeling pretty good about your investment today.According to our calculations, a $1000 investment made in June 2016 would be worth $4,786.75, or a gain of 378.68%, as of June 10, 2026, and this return excludes dividends but includes price increases.Compare this to the S&P 500's rally of 249.17% and gold's return of 221.00% over the same time frame.Looking ahead, analysts are expecting more upside for VEEV.Veeva Systems continues to benefit from broad demand for life sciences cloud platforms, with expansion in R&D and Quality solutions and steady progress in Vault CRM migrations. Management's fiscal 2027 outlook calls for mid-teens revenue growth and stable adjusted operating margin, assuming an unchanged macro environment, as newer products such as RTSM, Safety and LIMS scale and Crossix builds share in digital measurement. The balance sheet remains highly liquid and the company is returning capital through repurchases. Offsetting these positives, gross margin has compressed as infrastructure and services costs rise and commercial growth can be uneven during large migrations. Falcon's agentic AI initiative is early, with pricing and customer adoption still developing amid ongoing competition, limiting near-term upside.The stock is up 5.18% over the past four weeks, and no earnings estimate has gone lower in the past two months, compared to 5 higher, for fiscal 2026. The consensus estimate has moved up as well.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks